Zelira Therapeutics Limited (ASX:ZLD)
0.3500
0.00 (0.00%)
Apr 24, 2025, 3:24 PM AEST
Zelira Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
Cash & Equivalents | 0.04 | 0.59 | 0.15 | 2.75 | 4.97 | 1.7 | Upgrade
|
Cash & Short-Term Investments | 0.04 | 0.59 | 0.15 | 2.75 | 4.97 | 1.7 | Upgrade
|
Cash Growth | -41.10% | 300.91% | -94.68% | -44.75% | 192.93% | -44.78% | Upgrade
|
Accounts Receivable | 0.2 | 0.01 | -0.01 | 0.1 | 0.04 | - | Upgrade
|
Other Receivables | - | 2.3 | 0.01 | 0.16 | 0.02 | 0.06 | Upgrade
|
Receivables | 0.2 | 2.31 | -0 | 0.26 | 0.06 | 0.06 | Upgrade
|
Inventory | 1.33 | 1.25 | 1.53 | 1.96 | 0.87 | - | Upgrade
|
Prepaid Expenses | - | 0.11 | 0.1 | 0.12 | 0.19 | 0.07 | Upgrade
|
Total Current Assets | 1.57 | 4.26 | 1.77 | 5.08 | 6.09 | 1.83 | Upgrade
|
Property, Plant & Equipment | 0.19 | 0.23 | 0.52 | 0.85 | 1.24 | 1.58 | Upgrade
|
Long-Term Investments | - | - | - | - | 0.07 | 0.24 | Upgrade
|
Goodwill | - | - | 30.75 | 30.75 | - | 30.75 | Upgrade
|
Other Intangible Assets | 0.58 | 0.65 | 0.81 | 0.97 | 31.87 | 1.28 | Upgrade
|
Other Long-Term Assets | 0.05 | 0.04 | 0.04 | 0.06 | 0.1 | 0.11 | Upgrade
|
Total Assets | 2.39 | 5.18 | 33.89 | 37.7 | 39.37 | 35.79 | Upgrade
|
Accounts Payable | 4.06 | 3.41 | 1.74 | 1.51 | 0.98 | 0.56 | Upgrade
|
Short-Term Debt | 6.07 | 3.54 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.15 | 0.15 | 0.14 | 0.12 | 0.09 | 0.06 | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 0.05 | Upgrade
|
Total Current Liabilities | 10.28 | 7.09 | 1.88 | 1.63 | 1.08 | 0.67 | Upgrade
|
Long-Term Debt | - | 2.11 | - | - | - | - | Upgrade
|
Long-Term Leases | 0.08 | 0.15 | 0.3 | 0.38 | 0.46 | 0.57 | Upgrade
|
Total Liabilities | 10.36 | 9.36 | 2.18 | 2.01 | 1.54 | 1.24 | Upgrade
|
Common Stock | 45.52 | 45.52 | 45.52 | 43.75 | 36.65 | 26.08 | Upgrade
|
Retained Earnings | -83.75 | -81.34 | -44.77 | -39.19 | -27.25 | -18.7 | Upgrade
|
Comprehensive Income & Other | 29.83 | 31.31 | 31.05 | 30.65 | 28.43 | 27.17 | Upgrade
|
Total Common Equity | -8.4 | -4.51 | 31.8 | 35.2 | 37.83 | 34.55 | Upgrade
|
Minority Interest | 0.42 | 0.34 | -0.09 | 0.49 | - | - | Upgrade
|
Shareholders' Equity | -7.98 | -4.17 | 31.71 | 35.69 | 37.83 | 34.55 | Upgrade
|
Total Liabilities & Equity | 2.39 | 5.18 | 33.89 | 37.7 | 39.37 | 35.79 | Upgrade
|
Total Debt | 6.3 | 5.95 | 0.44 | 0.5 | 0.55 | 0.63 | Upgrade
|
Net Cash (Debt) | -6.26 | -5.36 | -0.29 | 2.25 | 4.42 | 1.06 | Upgrade
|
Net Cash Growth | - | - | - | -49.20% | 315.14% | -65.35% | Upgrade
|
Net Cash Per Share | -0.55 | -0.47 | -0.03 | 0.28 | 0.67 | 0.22 | Upgrade
|
Filing Date Shares Outstanding | 11.35 | 11.35 | 11.35 | 9.58 | 6.8 | 6.53 | Upgrade
|
Total Common Shares Outstanding | 11.35 | 11.35 | 11.35 | 9.58 | 6.8 | 5.52 | Upgrade
|
Working Capital | -8.71 | -2.83 | -0.11 | 3.45 | 5.01 | 1.16 | Upgrade
|
Book Value Per Share | -0.74 | -0.40 | 2.80 | 3.68 | 5.56 | 6.26 | Upgrade
|
Tangible Book Value | -8.98 | -5.17 | 0.24 | 3.49 | 5.96 | 2.52 | Upgrade
|
Tangible Book Value Per Share | -0.79 | -0.46 | 0.02 | 0.36 | 0.88 | 0.46 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.